Psoriasis. Psoriasis
Conditions
Interventions
Intervention group: Intervention group: This randomized clinical trial study will be conducted in two groups in parallel on patients with mild and moderate psoriasis. Allocation of patients to two gro
Sponsors
Gorgan University of Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to 60 Years
Inclusion criteria
Inclusion criteria: Patients with moderate and mild psoriasis
Exclusion criteria
Exclusion criteria: Patients with severe psoriasis Patients with kidney stone disease Suffering from uncontrolled cardiovascular, respiratory, hematological and urinary diseases
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Systemic immune inflammation and extent of the lesion and quality of life, intensity of itching, intensity of pain, scaling, redness, and prominence of the wound. Timepoint: On arrival and 4 weeks after phlebotomy. Method of measurement: The ratio of the product of the number of platelets and neutrophils to lymphocytes - the ratio of the product of the number of neutrophils and monocytes to lymphocytes. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public Contactmalihe rahnavard
Gorgan University of Medical Sciences
Outcome results
None listed